SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-19-001957
Filing Date
2019-04-04
Accepted
2019-04-04 16:19:51
Documents
56
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2237546z20-f.htm 20-F 1732117
2 EX-8.1 a2237546zex-8_1.htm EX-8.1 4372
3 EX-12.1 a2237546zex-12_1.htm EX-12.1 7869
4 EX-12.2 a2237546zex-12_2.htm EX-12.2 7869
5 EX-13.1 a2237546zex-13_1.htm EX-13.1 4716
6 EX-15.1 a2237546zex-15_1.htm EX-15.1 2742
  Complete submission text file 0001047469-19-001957.txt   8388527

Data Files

Seq Description Document Type Size
7 EX-101.INS fwp-20181231.xml EX-101.INS 2017420
8 EX-101.SCH fwp-20181231.xsd EX-101.SCH 87565
9 EX-101.CAL fwp-20181231_cal.xml EX-101.CAL 57166
10 EX-101.DEF fwp-20181231_def.xml EX-101.DEF 223587
11 EX-101.LAB fwp-20181231_lab.xml EX-101.LAB 590995
12 EX-101.PRE fwp-20181231_pre.xml EX-101.PRE 374284
Mailing Address OSTERGADE 24A, 1 COPENHAGEN G7 1100
Business Address OSTERGADE 24A, 1 COPENHAGEN G7 1100 0114533444242
Forward Pharma A/S (Filer) CIK: 0001604924 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36686 | Film No.: 19732488
SIC: 2834 Pharmaceutical Preparations